Ubaldo Visco-Comandini

7PUBLICATIONS
35CO-AUTHORS
Respiratory diseasesInnate immunityPredictive and prognostic markersDisease surveillanceRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2023
Humoral Immune Response after COVID-19 mRNA Vaccination in Patients with Liver Cirrhosis: A Prospective Real-Life Single Center Study.

Elisa Biliotti, Alessandro Caioli, Chiara Sorace

|Mar 17, 2023
Third dose of SARS-CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients.

Marzia Montalbano, Paola Piccolo, Raffaella Lionetti

|Oct 31, 2021
Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients.

Gianpiero D'Offizi, Chiara Agrati, Ubaldo Visco-Comandini

|Sep 01, 2021
Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping?

Renato Romagnoli, Salvatore Gruttadauria, Giuseppe Tisone

|Apr 04, 2018
Significance of detectable HCV RNA below the limit of quantification in patients treated with DAAs using standard and ultrasensitive protocols.

Ubaldo Visco-Comandini, Daniele Lapa, Raffaella Lionetti

|Dec 02, 2017
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study.

Raffaella Lionetti, Vincenza Calvaruso, Paola Piccolo

Pageof 2

Frequent Collaborators

4 joint publications

Raffaella Lionetti

2 joint publications

Marzia Montalbano

2 joint publications

Giuseppe Maria Ettorre

2 joint publications

Gianpiero D'Offizi